Pharmafile Logo

Amici Procurement Solutions

Amici provide cutting edge sourcing solutions to companies across the Biotech industry. Our business is to deliver greater savings through improved supplier performance. We can support you whether you are looking for an outsourced procurement resource or simply to save money quickly. We offer consortium deals, consultancy, training and a virtual purchasing resource. Uniquely, we also provide a savings guarantee.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

3 Centura Court, Nasmyth Place, Glasgow, G52 4PR
+44 (0)141 810 2580

 Latest Content from PMHub 

Infographic: Therapy Watch Hyperlipidaemia

White Papers and Resources | December 7, 2022 | Inizio

Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study.

Article: The rise of the healthcare influencer

White Papers and Resources | December 7, 2022 | Inizio

In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space.

ORIGINS cements its specialist position with a truly patient focused offering

Origins are the patient focused specialists that create and deliver strategy, insights, experience data and solutions across the product lifecycle

Demonstrating the value of UX research in pharma and healthcare

Press Releases | December 6, 2022 | Graphite Digital

Demonstrating the value of UX research in pharma and healthcare can be difficult. Here, Graphite's Senior Clinical UX Researcher, Jack Burton, explains the importance of user research within the digital...

Top-10 Reasons Why You Should be Adding Asynchronous Virtual Touchpoints Between Your Real-time Meetings

After more than two years of pandemic restrictions, many Pharma leaders are itching to meet with their key opinion leaders (KOLs) face-to-face again, believing that’s what most KOLs want. It may...

INTRODUCING SCIRIS

imc group reveals new brand identity

How to Increase Engagement During Virtual Events

Tip #2 - Are you team ""jump on a call"" or team ""just email me""? Instead of choosing just one, try using a combination of synchronous (real-time) and asynchronous (over-time,...

FREE WEBINAR: End-to-end patient strategy: making a treatment for patients, with patients

Origins announces the first speaker on the panel of our upcoming webinar

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

Press Releases | November 30, 2022 | Medscape Education

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

Press Releases | November 28, 2022 | OPEN Health

OPEN Health has announced additions to its board of directors, appointing David P. King as non-executive Chairman and Paul Carter as an independent board member.